FDA-cleared profile

syngo.CT Coronary Cockpit

Siemens Medical Solutions USA, Inc.

Authorized purpose: An extension for syngo.via that assists trained physicians with automated and semi-automated analysis, visualization and reporting of cardiac CT angiography volume datasets for coronary-lesion evaluation, documentation, follow-up and treatment planning.

Evidence status: each field states its source quality, applicability, and review date. Research pending, information not established, and vendor documentation pending remain distinct outcomes.

Product overview

Start with the essentials

Authorized purpose: An extension for syngo.via that assists trained physicians with automated and semi-automated analysis, visualization and reporting of cardiac CT angiography volume datasets for coronary-lesion evaluation, documentation, follow-up and treatment planning.

Overview status: Source-reviewed overview

Clinical takeaway

Clinical role: An extension for syngo.via that assists trained physicians with automated and semi-automated analysis, visualization and reporting of cardiac CT angiography volume datasets for coronary-lesion evaluation, documentation, follow-up and treatment planning.

Evidence takeaway

Evidence from the reviewed source record: Technical FDA testing used multi-country cardiac-CTA datasets; reported vessel-tracing results apply to the specified anatomical and image-quality criteria, not to clinical diagnosis or treatment benefit.

Clinical details

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
An extension for syngo.via that assists trained physicians with automated and semi-automated analysis, visualization and reporting of cardiac CT angiography volume datasets for coronary-lesion evaluation, documentation, follow-up and treatment planning.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Intended users
Trained users with appropriate skill, experience and judgment; a physician is responsible for confirming lesion presence or absence and clinical use of results.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Care setting and population
Cardiac CT angiography workflow; no care-site restriction was established in the reviewed FDA summary.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Workflow role
Automated and semi-automated coronary-vessel, lumen, wall and plaque analysis with reporting support.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Required input
Cardiac CT angiography volume datasets in the syngo.via environment.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Output and human action
Processed coronary-vessel visualization, quantification and reporting information for physician confirmation and documentation.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Limitations
The product does not replace clinical judgment. Interpolated CT data may cause tissue near or below scanning resolution to appear healthy; outputs require trained-user review.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K253786
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Anatomy
Heart/Cardiovascular
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2026-06-25
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
Operates as an extension for multi-modality reading on syngo.via.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06

Current View&GO documentation is family context only, not proof of exact VC10 deployment compatibility.

Deployment and data flow
Extension for the syngo.via software platform, not a standalone device.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06

The reviewed summary does not establish a site-specific hosting architecture.

Security and privacy
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-06

The reviewed material does not provide a dated, scoped installed-configuration security assessment.

Training and support
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-06

The summary requires trained users but does not establish a current vendor training program or site competency process.

Monitoring and change control
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-06

No verified product monitoring service was found. Site acceptance should evaluate coronary tracing review, edits, reporting and failure handling.

Current-family workstation requirements

The syngo.via View&GO VA55 operator manual lists Windows 11 64-bit, an Intel AVX2-capable CPU and at least 16 GB RAM when using syngo.CT Coronary Cockpit.

product family ยท checked 2026-09-06

VA55 documentation is later family context and does not establish the exact K253786 VC10 configuration.

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
Technical FDA testing used multi-country cardiac-CTA datasets; reported vessel-tracing results apply to the specified anatomical and image-quality criteria, not to clinical diagnosis or treatment benefit.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Reported sensitivity
95.8
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06

Vessel-tracing sensitivity for vessels at least 1.5 mm in the FDA technical-performance dataset; not diagnostic sensitivity for coronary disease.

Reported specificity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-06

No disease-detection specificity was established by the reviewed technical-performance summary.

Vessel-tracing sensitivity

95.8 percent

  • EndpointSensitivity of vessel tracing for coronary vessels at least 1.5 mm
  • Population425 cardiac-CTA datasets from five US states and three European countries; CT slice thickness 0.2-1.0 mm and 70-140 kVp
  • Tested versionsyngo.CT Coronary Cockpit (SOMARIS/8 VC10)

Coronary-vessel tracing failure rate

0 percent

  • EndpointFailure rate for the technical vessel-tracing evaluation
  • PopulationSame 425 cardiac-CTA technical-performance datasets
  • Tested versionsyngo.CT Coronary Cockpit (SOMARIS/8 VC10)

K253786 coronary CTA technical performance evaluation

  • DesignManufacturer technical-performance evaluation against expert/reference annotations
  • Population425 cardiac-CTA datasets for vessel tracing; random 150-dataset subset for lumen and wall evaluation
  • Scopeexact submission
  • Tested versionsyngo.CT Coronary Cockpit (SOMARIS/8 VC10)
  • Samplen=425
  • IndependenceSponsor or vendor study

K253786

The summary describes geographically diverse datasets and quantitative segmentation/tracing endpoints. It is not a prospective clinical-outcome study.

Costs and setup

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-06

No exact submission price or public procurement record reviewed.

Reimbursement and coding
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-09-06

No applicable CMS policy content reviewed; no coverage conclusion is made.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-06Last searched
22Fields reviewed
11Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

Stored PubMed and ClinicalTrials candidate metadata snapshots were screened; both arrays were empty. No candidate evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, acr ai central product, fda decision summary, vendor documentation, literature index, trial registry, stored candidate metadata, stored recall candidates, pubmed, clinical trials, openfda device recall

Sources & history

How this profile was documented

Open the ledger for source dates, scope, and research-record updates.

View source ledger and history

Source ledger

  1. FDA 510(k) K253786: syngo.CT Coronary Cockpit

    U.S. Food and Drug Administration - Accessed 2026-09-06

    Scope: identity, clinicalUse, modality, anatomy, implementationCapabilities, evidenceStudies, reportedSensitivity

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. syngo.CT Coronary Cockpit model card (K253786)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, reportedSensitivity, evidenceSummary, anatomy, evidenceStudies

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. syngo.via View&GO VA55 Operator Manual

    Siemens Healthineers - Accessed 2026-09-06

    Scope: productFamily, implementationCapabilities

Research history

  1. K253786 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K260169

AV Cardiac CT

Philips Medical Systems Nederland B.V.

AV Cardiac CT assists radiologists, cardiologists and 3D technologists with viewing, processing and analysis of gated cardiac CT data, including coronary anatomy and cardiac...

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2026-03-05
FDA-cleared K252217

CT VScore+

Canon Medical Informatics, Inc.

CT VScore+ evaluates calcified coronary lesions on ECG-gated, non-contrast cardiac CT in patients aged 30 years or older, automatically generating coronary calcium scores and...

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2025-11-28